Neuropathology of non-motor features of Parkinson disease

Parkinsonism and Related Disorders

Volumn 15, Issue SUPPL. 3, 2009, Pages

  Dickson, Dennis W ^a   Fujishiro, Hiroshige ^a   Orr, Carolyn ^b   DelleDonne, Anthony ^a   Josephs, Keith A ^b   Frigerio, Roberta ^b   Burnett, Melinda ^b   Parisi, Joseph E ^b   Klos, Kevin J ^c   Ahlskog, J Eric ^b  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

^c Neurological Associates of Tulsa   (United States)

Author keywords

Autonomic; Dementia; Hyposmia; Rapid eye movement sleep behavior disorder; Synucleinopathy

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; ANTIDEPRESSANT AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CHOLINESTERASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; TAU PROTEIN;

ALZHEIMER DISEASE; ANXIETY; ARTICLE; AUTONOMIC DYSFUNCTION; BEHAVIOR DISORDER; CARDIOVASCULAR SYMPTOM; CELL LOSS; CELL POPULATION; CHROMAFFIN CELL; CLINICAL FEATURE; DEGENERATIVE DISEASE; DEMENTIA; DEPRESSION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE SEVERITY; DOPAMINERGIC NERVE CELL; DOPAMINERGIC SYSTEM; DRUG RESPONSE; EXTRAPYRAMIDAL SYMPTOM; GASTROINTESTINAL SYMPTOM; HUMAN; HYPOSMIA; LEWY BODY; MESENCEPHALON; MOTOR DYSFUNCTION; NERVE CELL LESION; NIGRONEOSTRIATAL SYSTEM; PARASYMPATHETIC INNERVATION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN PHOSPHORYLATION; REM SLEEP; SUBSTANTIA NIGRA; SYMPATHETIC INNERVATION;

ALPHA-SYNUCLEIN; ANIMALS; ANXIETY; AUTONOMIC NERVOUS SYSTEM DISEASES; DEMENTIA; DEPRESSION; HUMANS; LEWY BODIES; PARKINSON DISEASE; REM SLEEP BEHAVIOR DISORDER;

EID: 71849089219     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1353-8020(09)70769-2     Document Type: Article

References (66)

1. Langston J.W. The Parkinson's complex: Parkinsonism is just the tip of the iceberg. Ann Neurol 59 (2006) 591-596
2. Galloway P.G., Mulvihill P., and Perry G. Filaments of Lewy bodies contain insoluble cytoskeletal elements. Am J Pathol 140 (1992) 809-822
3. Conway K.A., Harper J.D., and Lansbury Jr. P.T. Fibrils formed in vitro from alpha synuclein and two mutant forms linked to Parkinson's disease are typical amyloid. Biochemistry 39 (2000) 2552-2563
4. Neumann M., Muller V., Kretzschmar H.A., Haass C., and Kahle P.J. Regional distribution of proteinase k-resistant alpha-synuclein correlates with Lewy body disease stage. J Neuropathol Exp Neurol 63 (2004) 1225-1235
5. Takeda A., Hashimoto M., Mallory M., Sundsumo M., Hansen L., Sisk A., and Masliah E. Abnormal distribution of the non-abeta component of alzheimer's disease amyloid precursor/alpha-synuclein in Lewy body disease as revealed by proteinase k and formic acid pretreatment. Lab Invest 78 (1998) 1169-1177
6. Dickson D.W., Schmidt M.L., Lee V.M., Zhao M.L., Yen S.H., and Trojanowski J.Q. Immunoreactivity profile of hippocampal ca2/3 neurites in diffuse Lewy body disease. Acta Neuropathol 87 (1994) 269-276
7. Braak H., Sandmann-Keil D., Gai W., and Braak E. Extensive axonal Lewy neurites in Parkinson's disease: A novel pathological feature revealed by alpha-synuclein immunocytochemistry. Neurosci Lett 265 (1999) 67-69
8. Irizarry M.C., Growdon W., Gomez-Isla T., Newell K., George J.M., Clayton D.F., and Hyman B.T. Nigral and cortical Lewy bodies and dystrophic nigral neurites in Parkinson's disease and cortical Lewy body disease contain alpha-synuclein immunoreactivity. J Neuropathol Exp Neurol 57 (1998) 334-337
9. Wakabayashi K., Hayashi S., Yoshimoto M., Kudo H., and Takahashi H. Nacp/alpha synuclein-positive filamentous inclusions in astrocytes and oligodendrocytes of Parkinson's disease brains. Acta Neuropathol (Berl) 99 (2000) 14-20
10. Gai W.P., Power J.H., Blumbergs P.C., and Blessing W.W. Multiple-system atrophy: A new alpha-synuclein disease?. Lancet 352 (1998) 547-548
11. Parkkinen L., Pirttila T., Tervahauta M., and Alafuzoff I. Widespread and abundant alpha-synuclein pathology in a neurologically unimpaired subject. Neuropathology 25 (2005) 304-314
12. McGeer P.L., and McGeer E.G. Glial reactions in Parkinson's disease. Mov Disord 23 (2008) 474-483
13. Jellinger K.A., and Mizuno Y. Parkinson's disease. In: Dickson D.W. (Ed). Neurodegeneration: The molecular pathology of dementia and movement disorders (2003), ISN Neuropath Press, Basel 159-187
14. Braak H., Del Tredici K., Rub U., de Vos R.A., Jansen Steur E.N., and Braak E. Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24 (2003) 197-211
15. Braak H., and Del Tredici K. Neuroanatomy and pathology of sporadic Parkinson's disease. Advances in anatomy, embryology, and cell biology 201 (2009) 1-119
16. Stoessl A.J. Prevention and management of late stage complications in Parkinson's disease. Can J Neurol Sci 19 (1992) 113-116
17. Singer C., Weiner W.J., and Sanchez-Ramos J.R. Autonomic dysfunction in men with Parkinson's disease. Eur Neurol 32 (1992) 134-140
18. Orimo S., Amino T., Itoh Y., Takahashi A., Kojo T., Uchihara T., et al. Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease. Acta Neuropathol (Berl) 109 (2005) 583-588
19. Forno L.S., and Norville R.L. Ultrastructure of Lewy bodies in the stellate ganglion. Acta Neuropathol 34 (1976) 183-197
20. Orimo S., Uchihara T., Nakamura A., Mori F., Kakita A., Wakabayashi K., et al. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. Brain 131 (2008) 642-650
21. Fujishiro H., Frigerio R., Burnett M., Klos K.J., Josephs J.A., DelleDonne A., et al. Cardiac sympathetic denervation correlates with clinical and pathologic stages of Parkinson's disease. Mov Disord 23 (2008) [in press].
22. Orimo S., Takahashi A., Uchihara T., Mori F., Kakita A., Wakabayashi K., et al. Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson's disease. Brain Pathol 17 (2007) 24-30
23. Orimo S., Ozawa E., Nakade S., Sugimoto T., and Mizusawa H. (123)i-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatry 67 (1999) 189-194
24. Wenning G.K., Scherfler C., Granata R., Bosch S., Verny M., Chaudhuri K.R., et al. Time course of symptomatic orthostatic hypotension and urinary incontinence in patients with postmortem confirmed parkinsonian syndromes: A clinicopathological study. J Neurol Neurosurg Psychiatry 67 (1999) 620-623
25. Arai K., Kato N., Kashiwado K., and Hattori T. Pure autonomic failure in association with human alpha-synucleinopathy. Neurosci Lett 296 (2000) 171-173
26. Abbott R.D., Ross G.W., Petrovitch H., Tanner C.M., Davis D.G., Masaki K.H., et al. Bowel movement frequency in late-life and incidental Lewy bodies. Mov Disord 22 (2007) 1581-1586
27. Del Tredici K., Rub U., De Vos R.A., Bohl J.R., and Braak H. Where does Parkinson disease pathology begin in the brain?. J Neuropathol Exp Neurol 61 (2002) 413-426
28. Wakabayashi K., Takahashi H., Takeda S., Ohama E., and Ikuta F. Parkinson's disease: The presence of Lewy bodies in Auerbach's and Meissner's plexuses. Acta Neuropathol 76 (1988) 217-221
29. Braak H., de Vos R.A., Bohl J., and Del Tredici K. Gastric alpha-synuclein immunoreactive inclusions in Meissner's and Auerbach's plexuses in cases staged for Parkinson's disease-related brain pathology. Neurosci Lett 396 (2006) 67-72
30. Fumimura Y., Ikemura M., Saito Y., Sengoku R., Kanemaru K., Sawabe M., et al. Analysis of the adrenal gland is useful for evaluating pathology of the peripheral autonomic nervous system in Lewy body disease. J Neuropathol Exp Neurol 66 (2007) 354-362
31. Ikemura M., Saito Y., Sengoku R., Sakiyama Y., Hatsuta H., Kanemaru K., et al. Lewy body pathology involves cutaneous nerves. J Neuropathol Exp Neurol 67 (2008) 945-953
32. Kupsky W.J., Grimes M.M., Sweeting J., Bertsch R., and Cote L.J. Parkinson's disease and megacolon: Concentric hyaline inclusions (Lewy bodies) in enteric ganglion cells. Neurology 37 (1987) 1253-1255
33. Lebouvier T., Chaumette T., Damier P., Coron E., Touchefeu Y., Vrignaud S., et al. Pathological lesions in colonic biopsies during Parkinson's disease. Gut 57 (2008) 1741-1743
34. Katzenschlager R., and Lees A.J. Olfaction and Parkinson's syndromes: Its role in differential diagnosis. Curr Opin Neurol 17 (2004) 417-423
35. Ponsen M.M., Stoffers D., Booij J., van Eck-Smit B.L., Wolters E., and Berendse H.W. Idiopathic hyposmia as a preclinical sign of Parkinson's disease. Ann Neurol 56 (2004) 173-181
36. Serby M., Larson P., and Kalkstein D. The nature and course of olfactory deficits in alzheimer's disease. Am J Psychiatry 148 (1991) 357-360
37. Lee J.H., Goedert M., Hill W.D., Lee V.M., and Trojanowski J.Q. Tau proteins are abnormally expressed in olfactory epithelium of Alzheimer patients and developmentally regulated in human fetal spinal cord. Exp Neurol 121 (1993) 93-105
38. Witt M., Bormann K., Gudziol V., Pehlke K., Barth K., Minovi A., et al. Biopsies of olfactory epithelium in patients with Parkinson's disease. Mov Disord 24 (2009) 906-914
39. Shiba M., Bower J.H., Maraganore D.M., McDonnell S.K., Peterson B.J., Ahlskog J.E., et al. Anxiety disorders and depressive disorders preceding Parkinson's disease: A case-control study. Mov Disord 15 (2000) 669-677
40. Ballard C.G., Jacoby R., Del Ser T., Khan M.N., Munoz D.G., Holmes C., et al. Neuropathological substrates of psychiatric symptoms in prospectively studied patients with autopsy-confirmed dementia with Lewy bodies. Am J Psychiatry 161 (2004) 843-849
41. Tandberg E., Larsen J.P., Aarsland D., Laake K., and Cummings J.L. Risk factors for depression in Parkinson disease. Arch Neurol 54 (1997) 625-630
42. Hughes T.A., Ross H.F., Musa S., Bhattacherjee S., Nathan R.N., Mindham R.H., et al. A 10-year study of the incidence of and factors predicting dementia in Parkinson's disease. Neurology 54 (2000) 1596-1602
43. Richard I.H. Anxiety disorders in Parkinson's disease. Adv Neurol 96 (2005) 42-55
44. Halliday G.M., Li Y.W., Blumbergs P.C., Joh T.H., Cotton R.G., Howe P.R., Blessing W.W., et al. Neuropathology of immunohistochemically identified brainstem neurons in Parkinson's disease. Ann Neurol 27 (1990) 373-385
45. Jellinger K.A. Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. Mol Chem Neuropathol 14 (1991) 153-197
46. Boeve B.F., Silber M.H., Ferman T.J., Kokmen E., Smith G.E., Ivnik R.J., et al. REM sleep behavior disorder and degenerative dementia: An association likely reflecting Lewy body disease. Neurology 51 (1998) 363-370
47. Schenck C.H., Bundlie S.R., and Mahowald M.W. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behaviour disorder. Neurology 46 (1996) 388-393
48. Boeve B.F., Dickson D.W., Olson E.J., Shepard J.W., Silber M.H., Ferman T.J., et al. Insights into rem sleep behavior disorder pathophysiology in brainstem-predominant Lewy body disease. Sleep Med 8 (2007) 60-64
49. Lai Y.Y., and Siegel J.M. Physiological and anatomical link between Parkinson-like disease and rem sleep behavior disorder. Mol Neurobiol 27 (2003) 137-152
50. Stiasny-Kolster K., Doerr Y., Moller J.C., Hoffken H., Behr T.M., Oertel W.H., et al. Combination of 'idiopathic' rem sleep behaviour disorder and olfactory dysfunction as possible indicator for alpha-synucleinopathy demonstrated by dopamine transporter FP-CIT-SPECT. Brain 128 (2005) 126-137
51. Buter T.C., van den Hout A., Matthews F.E., Larsen J.P., Brayne C., and Aarsland D. Dementia and survival in Parkinson disease: a 12-year population study. Neurology 70 (2008) 1017-1022
52. Hely M.A., Reid W.G., Adena M.A., Halliday G.M., and Morris J.G. The Sydney multicenter study of Parkinson's disease: the inevitability of dementia at 20 years. Mov Disord 23 (2008) 837-844
53. Aarsland D., Andersen K., Larsen J.P., Lolk A., Nielsen H., and Kragh-Sorensen P. Risk of dementia in Parkinson's disease: A community-based, prospective study. Neurology 56 (2001) 730-736
54. Halliday G., Hely M., Reid W., and Morris J. The progression of pathology in longitudinally followed patients with Parkinson's disease. Acta Neuropathol 115 (2008) 409-415
55. Emre M., Aarsland D., Brown R., Burn D.J., Duyckaerts C., Mizuno Y., et al. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord 22 (2007) 1689-1707 quiz: 1837.
56. Nakano I., and Hirano A. Parkinson's disease: Neuron loss in the nucleus basalis without concomitant Alzheimer's disease. Ann Neurol 15 (1984) 415-418
57. Whitehouse P.J., Hedreen J.C., White III C.L., and Price D.L. Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol 13 (1983) 243-248
58. Candy J.M., Perry R.H., Perry E.K., Irving D., Blessed G., Fairbairn A.F., et al. Pathological changes in the nucleus of Meynert in Alzheimer's and Parkinson's diseases. J Neurol Sci 59 (1983) 277-289
59. Perry E.K., Marshall E., Perry R.H., Irving D., Smith C.J., Blessed G., et al. Cholinergic and dopaminergic activities in senile dementia of Lewy body type. Alzheimer Dis Assoc Disord 4 (1990) 87-95
60. Apaydin H., Ahlskog J.E., Parisi J.E., Boeve B.F., and Dickson D.W. Parkinson disease neuropathology: Later-developing dementia and loss of the levodopa response. Arch Neurol 59 (2002) 102-112
61. Hurtig H.I., Trojanowski J.Q., Galvin J., Ewbank D., Schmidt M.L., Lee V.M., et al. Alpha synuclein cortical Lewy bodies correlate with dementia in Parkinson's disease. Neurology 54 (2000) 1916-1921
62. Churchyard A., and Lees A.J. The relationship between dementia and direct involvement of the hippocampus and amygdala in Parkinson's disease. Neurology 49 (1997) 1570-1576
63. Zaccai J., Brayne C., McKeith I., Matthews F., and Ince P.G. Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort. Neurology 70 (2008) 1042-1048
64. Klunk W.E., Engler H., Nordberg A., Wang Y., Blomqvist G., Holt D.P., et al. Imaging brain amyloid in alzheimer's disease with Pittsburgh compound-b. Ann Neurol 55 (2004) 306-319
65. Edison P., Rowe C.C., Rinne J.O., Ng S., Ahmed I., Kemppainen N., et al. Amyloid load in Parkinson's disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. J Neurol Neurosurg Psychiatry 79 (2008) 1331-1338
66. Pletnikova O., West N., Lee M.K., Rudow G.L., Skolasky R.L., Dawson T.M., et al. Abeta deposition is associated with enhanced cortical alpha-synuclein lesions in Lewy body diseases. Neurobiol Aging 26 (2005) 1183-1192